Bai Song Mei
Vermögen: 5 Mio $ am 30.09.2026
Vermögen: 5 Mio $ am 30.09.2026
Dr. Bai Song Mei is a Chief Medical Officer at City Therapeutics, Inc. Dr. Mei was previously employed as a Chief Medical Officer & Executive Vice President by Editas Medicine, Inc. and a Senior Global Project Head-Rare Disease by Sanofi.
He received his doctorate degree from the University of Toledo (Ohio).
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,44 % | 15.10.2026 | 228.743 ( 0,44 % ) | 5 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|
| Unternehmen | Position | Ende |
|---|---|---|
| EDITAS MEDICINE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2024 |
| SANOFI | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Toledo (Ohio)
University of Toledo (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Bengbu Medical College
Bengbu Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wuhan University School of Law
Wuhan University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen